El interés en corto de Meihua Intl Medical Techs da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Meihua Intl Medical Techs. Los datos de interés en corto se actualizan cada dos semanas.

Meihua Intl Medical Techs (NASDAQ:MHUA) Bolsa, Informe de interés en corto

Meihua Intl Medical Techs

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Meihua International Medical Technologies Co., Ltd. - Ordinary Shares

Meihua International Medical Technologies Co Ltd

Riot Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) has outperformed the market over the past 5 years by 19.27% on an annualized basis producing an average annual return of 33.81%. Currently, Riot Platforms has a market capitalization of $2.19 billion. 
Buying $100 In RIOT: If an investor had bought $100 of RIOT stock 5 years ago, it would be worth $421.51 today based on a price of $7.23 for RIOT at the time of writing.
<h3>Riot Platforms's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727901324_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

RIOT

Here's How Much $100 Invested In Riot Platforms 5 Years Ago Would Be Worth Today

Ecolab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECL#NYSE">ECL</a>) has outperformed the market over the past 20 years by 2.39% on an annualized basis producing an average annual return of 10.81%. Currently, Ecolab has a market capitalization of $72.26 billion. 
Buying $100 In ECL: If an investor had bought $100 of ECL stock 20 years ago, it would be worth $781.21 today based on a price of $253.97 for ECL at the time of writing.
<h3>Ecolab's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727901319_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Ecolab 20 Years Ago Would Be Worth Today

President Joe Biden and his administration purchased an additional <a href="https://www.benzinga.com/markets/eurozone/24/10/41146905/geopolitical-risks-may-be-biggest-threat-to-markets-boe-says">6 million barrels of crude oil</a> earlier this week. 
The acquisition is meant to fill the Strategic Petroleum Reserve. The price tag came in at an average price of $68.56 per barrel, according to Patrick De Haan aka <a href="https://x.com/GasBuddyGuy/status/1840864888291242330">@GasBuddyGuy on X.</a> 
This is just the latest move in a series of oil trades executed by Biden's administration to stabilize the market.
Read Also: <a href="https://www.benzinga.com/trading-ideas/24/10/41144492/brent-crude-oil-prices-rise-amid-geopolitical-tensions">Brent Crude Oil Prices Rise Amid Geopolitical Tensions</a>
The Context: In 2022, Biden ordered the release of more than 100 million barrels of <a href="https://www.benzinga.com/government/24/02/36914512/biden-the-master-oil-trader-part-iii-president-refills-emergency-stash-as-crude-price-slides">oil from the SPR </a>after Russia invaded Ukraine. That created a supply shock in the oil markets. At the time, oil sold for more than $100 per barrel. But, through the release of oil from the SPR, Biden's administration managed to calm the markets, with oil returning to a more normal price of around $80 per barrel. Since then, Biden's team has used periods of weakness in the oil markets to repurchase oil to refill the reserve after releasing a significant amount in 2022.<a href="https://www.benzinga.com/trading-ideas/24/10/41144492/brent-crude-oil-prices-rise-amid-geopolitical-tensions"> </a><a href="https://www.benzinga.com/trading-ideas/24/10/41144492/brent-crude-oil-prices-rise-amid-geopolitical-tensions"> </a>"DOE announces another 6 million barrels of crude oil have been purchased for the SPR, for delivery Feb thru May of 2025," <a href="https://x.com/GasBuddyGuy/status/1840864888291242330">De Haan tweeted Monday.</a> "DOE has now purchased over 55 million barrels to refill the SPR."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">BREAKING: DOE announces another 6 million barrels of crude oil have been purchased for the SPR, for delivery Feb thru May of 2025. DOE has now purchased over 55 million barrels to refill the SPR.
&mdash; Patrick De Haan &#x26fd;&#xFE0F;&#x1f4ca; (@GasBuddyGuy) <a href="https://twitter.com/GasBuddyGuy/status/1840864888291242330?ref_src=twsrc%5Etfw">September 30, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Quoted: Todd Campbell, the editor-in-chief of TheStreet,<a href="https://x.com/ebcapital/status/1840923025690018087"> responded </a>to De Haan's tweet, saying Biden's move "has to be one of the best oil trades in history." While the administration still has not fully refilled the SPR to its pre-Russia invasion levels, the trades showcase how governments may intervene to help stabilize markets in times of uncertainty. When Biden originally released millions of barrels of oil from the SPR, gas prices were skyrocketing, putting pressure on American consumers. The release from the SPR led to a 40-cent-per-gallon decrease in gas prices, according to the Department of Energy. Now, as gas prices have returned to relatively normal levels, the administration's focus has shifted to refilling the SPR. On Wednesday, the United States Oil Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>), a fund that roughly tracks the price of oil, fell by more than 2% intraday amid ongoing unrest and uncertainty in the Middle East. The Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) also fell early in the trading day, but erased some of those losses and was in the green as of late in Wednesday's session. Keep Reading: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41143156/oil-prices-spike-energy-stocks-jump-after-irans-missile-attack-on-israel-what-investors-need-to-know">Oil Prices Spike, Energy Stocks Jump After Iran&#8217;s Missile Attack On Israel: What Investors Need To Know</a></li>
</ul>
Image: Shutterstock

Commodities

Politics

Markets

General

Biden The Master Oil Trader Part IV? President Loads Up On Millions Of Barrels To Refill Emergency Stash In 'One Of The Best Oil Trades In History'

<ul>
<li>Maximum USD 100 million to purchase up to an aggregate of 10,000,000 of the Company's common shares, with 1,507,328 shares repurchased for USD 11,629,758 as of the date hereof. &nbsp;</li>
<li>A period from and including 5 October 2024 to and including 4 October 2025.
<ul>
<li>The share buy-backs will be carried out by way of repurchases in the market, both on the Oslo Stock Exchange and on Nasdaq.</li>
</ul>
</li>
</ul>

Buybacks

GOGL

Golden Ocean Group Extends Existing Buy-Back Program With 12 Months

Maryland American Water Receives Commission Approval For Acquisition Of Severn Water Company For ~$1.6M

Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) shares are trading lower following the company&#8217;s third-quarter financial results released after Wednesday&#8217;s closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/24/10/b41150661/levi-strauss-co-reports-third-quarter-2024-financial-results">details from the report. </a>
The Details: Levi Strauss reported quarterly earnings of 33 cents per share, which beat the analyst consensus estimate of 31 cents. Quarterly revenue came in at $1.516 billion, which missed the analyst consensus estimate of $1.55 billion.
<ul>
<li>DTC (Direct-to-Consumer) net revenues increased 10% on a reported basis and 12% on a constant-currency basis. DTC growth reflected a 12% increase in the U.S. and a 9% increase in Europe.</li>
<li>Wholesale net revenues decreased 6% on a reported basis and 5% on a constant-currency basis. Adjusting for the exit of the Denizen business, wholesale net revenues declined 3%.</li>
<li>Operating margin was 2.0% compared to 2.3% in the same quarter last year inclusive of an impairment charge of $111 million related to the Beyond Yoga acquisition.</li>
<li>Gross margin increased 440 basis points to 60% from 55.6% in the same quarter last year primarily driven by lower product costs and favorable channel and brand mix.</li>
</ul>
Read Next: <a href="https://www.benzinga.com/news/24/10/41129365/what-happened-with-rivian-stock-today">What Happened With Rivian Stock Today?</a>
&#8220;The underlying fundamentals of our business are getting stronger, driven by the Levi&#8217;s&#xAE; brand, which grew 5% globally in Q3, a significant acceleration from H1 and the highest revenue growth in two years. We are making progress against our strategic priorities, including double-digit growth in our direct-to-consumer business, continued positive performance in the U.S., and Europe inflecting to growth,&#8221; said Michelle Gass, CEO of Levi Strauss &amp; Co.
Outlook: Levi Strauss sees fiscal year 2024 adjusted earnings at a mid-point of between $1.17 and $1.27 per share, versus the $1.25 estimate. 
LEVI Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Levi Strauss shares are down 6.22% after-hours at $19.75 after dropping 2.86% in Wednesday&#8217;s regular trading session.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/41104861/elon-musk-tesla-win-dismissal-of-full-self-driving-claims-judge-tosses-lawsuit">Elon Musk, Tesla Win Dismissal Of Full-Self Driving Claims: Judge Tosses Lawsuit</a></li>
</ul>
Photo: Courtesy of Levi Strauss &amp; Co.

Earnings

After-Hours Center

Movers

LEVI

Levi Strauss & Co Stock Falls After Mixed Q3 Results: EPS Beat, Revenues Miss

The Lydian Includes 129 Homes And 23K Sq Ft Of Office/Retail Space; Acquisition Financed Through $35M Mortgage Debt, $14.5M In Operating Partnership Units, And Cash

Centerspace Expands Denver Presence With $54M Acquisition Of The Lydian; Completes Redemption Of 6.625% Series C Preferred Shares; YTD ATM Sales Of 1.59M Shares With $113.73M In Gross Proceeds Used For Preferred Share Redemption And Debt Pay Down

Whales with a lot of money to spend have taken a noticeably bearish stance on Zscaler.
Looking at options history for Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 22% of the investors opened trades with bullish expectations and 55% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $365,000 and 7, calls, for a total amount of $1,123,045.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $135.0 to $230.0 for Zscaler over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Zscaler's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Zscaler's substantial trades, within a strike price spectrum from $135.0 to $230.0 over the preceding 30 days.
<h3>Zscaler 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727901137_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ZS</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$11.6</td>
<td>$10.85</td>
<td>$11.25</td>
<td>$180.00</td>
<td>$675.0K</td>
<td>820</td>
<td style="text-align: right;">600</td>
</tr>
<tr>
<td>ZS</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$11.3</td>
<td>$10.65</td>
<td>$11.0</td>
<td>$135.00</td>
<td>$275.0K</td>
<td>18</td>
<td style="text-align: right;">250</td>
</tr>
<tr>
<td>ZS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$40.7</td>
<td>$40.55</td>
<td>$40.55</td>
<td>$145.00</td>
<td>$93.2K</td>
<td>108</td>
<td style="text-align: right;">23</td>
</tr>
<tr>
<td>ZS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$8.1</td>
<td>$7.5</td>
<td>$7.5</td>
<td>$175.00</td>
<td>$90.0K</td>
<td>253</td>
<td style="text-align: right;">120</td>
</tr>
<tr>
<td>ZS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$38.0</td>
<td>$37.3</td>
<td>$37.3</td>
<td>$150.00</td>
<td>$89.5K</td>
<td>2.6K</td>
<td style="text-align: right;">95</td>
</tr>
</tbody>
</table>

<h3>About Zscaler</h3>
Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.
Following our analysis of the options activities associated with Zscaler, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Zscaler</h3>
<ul>
<li>With a volume of 1,255,322, the price of ZS is up 1.52% at $169.53. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 54 days.</li>
</ul>
<h3>What Analysts Are Saying About Zscaler</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $206.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Zscaler with a target price of $220. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on Zscaler, which currently sits at a price target of $200. 
&#x2A; Maintaining their stance, an analyst from Needham continues to hold a Strong Buy rating for Zscaler, targeting a price of $235. 
&#x2A; Consistent in their evaluation, an analyst from BTIG keeps a Buy rating on Zscaler with a target price of $205. 
&#x2A; An analyst from Cantor Fitzgerald has decided to maintain their Neutral rating on Zscaler, which currently sits at a price target of $170. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Zscaler, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Decoding Zscaler's Options Activity: What's the Big Picture?

Whales with a lot of money to spend have taken a noticeably bearish stance on Accenture.
Looking at options history for Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 22% of the investors opened trades with bullish expectations and 66% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $260,055 and 3, calls, for a total amount of $120,743.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $320.0 and $380.0 for Accenture, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Accenture's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Accenture's significant trades, within a strike price range of $320.0 to $380.0, over the past month.
<h3>Accenture Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727901133_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ACN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$35.7</td>
<td>$33.8</td>
<td>$35.7</td>
<td>$370.00</td>
<td>$89.2K</td>
<td>62</td>
<td style="text-align: right;">35</td>
</tr>
<tr>
<td>ACN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$15.7</td>
<td>$15.6</td>
<td>$15.6</td>
<td>$360.00</td>
<td>$56.1K</td>
<td>1.0K</td>
<td style="text-align: right;">49</td>
</tr>
<tr>
<td>ACN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$1.5</td>
<td>$1.45</td>
<td>$1.5</td>
<td>$325.00</td>
<td>$47.2K</td>
<td>252</td>
<td style="text-align: right;">331</td>
</tr>
<tr>
<td>ACN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$27.7</td>
<td>$26.8</td>
<td>$27.7</td>
<td>$370.00</td>
<td>$38.7K</td>
<td>57</td>
<td style="text-align: right;">18</td>
</tr>
<tr>
<td>ACN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$35.6</td>
<td>$33.2</td>
<td>$35.6</td>
<td>$370.00</td>
<td>$35.6K</td>
<td>62</td>
<td style="text-align: right;">50</td>
</tr>
</tbody>
</table>

<h3>About Accenture</h3>
Accenture is a leading global IT-services firm that provides consulting, strategy, and technology and operational services. These services run the gamut from aiding enterprises with digital transformation to procurement services to software system integration. The company provides its IT offerings to a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture employs just under 500,000 people throughout 200 cities in 51 countries.
After a thorough review of the options trading surrounding Accenture, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Accenture</h3>
<ul>
<li>With a volume of 2,228,852, the price of ACN is up 1.22% at $356.29. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 78 days.</li>
</ul>
<h3>Expert Opinions on Accenture</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $376.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from B of A Securities has decided to maintain their Buy rating on Accenture, which currently sits at a price target of $388. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Accenture with a target price of $376. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Neutral rating for Accenture, targeting a price of $329. 
&#x2A; Consistent in their evaluation, an analyst from BMO Capital keeps a Market Perform rating on Accenture with a target price of $390. 
&#x2A; Showing optimism, an analyst from TD Cowen upgrades its rating to Buy with a revised price target of $400. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Accenture with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Spotlight on Accenture: Analyzing the Surge in Options Activity

Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna.
Looking at options history for Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) we detected 44 trades.
If we consider the specifics of each trade, it is accurate to state that 63% of the investors opened trades with bullish expectations and 29% with bearish.
From the overall spotted trades, 30 are puts, for a total amount of $2,727,271 and 14, calls, for a total amount of $652,606.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $40.0 to $175.0 for Moderna over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1078.22 with a total volume of 29,102.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Moderna's big money trades within a strike price range of $40.0 to $175.0 over the last 30 days.
<h3>Moderna Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727901128_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$8.25</td>
<td>$8.0</td>
<td>$8.05</td>
<td>$55.00</td>
<td>$1.0M</td>
<td>1.4K</td>
<td>1.2K</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$22.9</td>
<td>$22.0</td>
<td>$22.4</td>
<td>$75.00</td>
<td>$232.9K</td>
<td>1.3K</td>
<td>104</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$6.15</td>
<td>$5.75</td>
<td>$6.05</td>
<td>$50.00</td>
<td>$229.2K</td>
<td>1.2K</td>
<td>1.0K</td>
</tr>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$8.9</td>
<td>$7.0</td>
<td>$7.0</td>
<td>$95.00</td>
<td>$138.6K</td>
<td>5</td>
<td>198</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$37.4</td>
<td>$37.3</td>
<td>$37.4</td>
<td>$100.00</td>
<td>$127.1K</td>
<td>3.5K</td>
<td>34</td>
</tr>
</tbody>
</table>

<h3>About Moderna</h3>
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
After a thorough review of the options trading surrounding Moderna, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Moderna</h3>
<ul>
<li>Trading volume stands at 4,087,379, with MRNA's price down by -1.17%, positioned at $63.18.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 29 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Moderna with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

MRNA

Moderna Unusual Options Activity For October 02

Management

HTBK

Heritage Commerce Appoints Thomas Sa As COO Of Company And The Bank

<h3>Gainers</h3>
<ul>
<li>Thunder Power Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIEV#NASDAQ">AIEV</a>) stock increased by 15.6% to $0.55 during Wednesday's after-market session. The company's market cap stands at $38.6 million. </li>
<li>Jowell Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JWEL#NASDAQ">JWEL</a>) shares increased by 11.16% to $2.27. The company's market cap stands at $4.9 million. </li>
<li>Kaixin Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KXIN#NASDAQ">KXIN</a>) stock increased by 9.55% to $0.37. The market value of their outstanding shares is at $22.3 million. </li>
<li>AYRO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYRO#NASDAQ">AYRO</a>) shares moved upwards by 4.99% to $0.86. The company's market cap stands at $5.9 million. </li>
<li>Lovesac (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOVE#NASDAQ">LOVE</a>) shares increased by 4.98% to $27.57. The market value of their outstanding shares is at $428.9 million. </li>
<li>Yoshitsu Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKLF#NASDAQ">TKLF</a>) shares moved upwards by 4.91% to $0.58. The market value of their outstanding shares is at $24.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Levi Strauss (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) shares fell 7.0% to $19.58 during Wednesday's after-market session. The company's market cap stands at $7.7 billion. As per the news, the Q3 earnings report came out today. </li>
<li>E-Home Household Service (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EJH#NASDAQ">EJH</a>) stock decreased by 3.81% to $1.01. The market value of their outstanding shares is at $8.6 million. </li>
<li>Color Star Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) shares fell 3.81% to $1.01. The market value of their outstanding shares is at $57.0 million. </li>
<li>Genius Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GNS#AMEX">GNS</a>) shares fell 3.73% to $0.9. The market value of their outstanding shares is at $19.5 million. </li>
<li>Life Time Group Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LTH#NYSE">LTH</a>) shares decreased by 3.42% to $23.2. The market value of their outstanding shares is at $4.7 billion. </li>
<li>SRIVARU Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVMH#NASDAQ">SVMH</a>) shares fell 2.44% to $0.08. The company's market cap stands at $2.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIEV

AYRO

JWEL

KXIN

LOVE

SVMH

TKLF

12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Carmell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) stock rose 31.0% to $0.46 during Wednesday's after-market session. The company's market cap stands at $9.6 million. </li>
<li>Processa Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) shares rose 30.07% to $1.73. The market value of their outstanding shares is at $5.6 million. </li>
<li>China Pharma Holdings, Inc. Common Stock (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CPHI#AMEX">CPHI</a>) stock rose 8.83% to $0.28. </li>
<li>Eagle Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGRX#NASDAQ">EGRX</a>) shares increased by 7.94% to $2.31. The market value of their outstanding shares is at $29.9 million. </li>
<li>Bone Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBLG#NASDAQ">BBLG</a>) stock moved upwards by 7.89% to $1.64. The company's market cap stands at $2.9 million. </li>
<li>Conduit Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) shares increased by 7.36% to $0.1. The market value of their outstanding shares is at $9.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) stock declined by 8.6% to $4.45 during Wednesday's after-market session. The company's market cap stands at $10.1 million. </li>
<li>Inspire Veterinary (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVP#NASDAQ">IVP</a>) shares fell 6.34% to $0.28. The company's market cap stands at $2.1 million. </li>
<li>Kairos Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KAPA#AMEX">KAPA</a>) stock decreased by 5.3% to $1.25. The company's market cap stands at $16.0 million. </li>
<li>Gossamer Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOSS#NASDAQ">GOSS</a>) stock declined by 4.77% to $1.0. The market value of their outstanding shares is at $226.2 million. </li>
<li>Fractyl Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GUTS#NASDAQ">GUTS</a>) shares fell 4.75% to $2.21. The market value of their outstanding shares is at $105.9 million. </li>
<li>TNF Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNFA#NASDAQ">TNFA</a>) shares fell 4.66% to $1.64. The market value of their outstanding shares is at $3.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBLG

CPHI

CTCX

EGRX

GOSS

GUTS

KAPA

PCSA

SNGX

TNFA

12 Health Care Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Graphex Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GRFX#AMEX">GRFX</a>) stock moved upwards by 15.0% to $0.24 during Wednesday's after-market session. The market value of their outstanding shares is at $12.1 million. </li>
<li>Lucas GC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGCL#NASDAQ">LGCL</a>) stock rose 3.96% to $1.05. The company's market cap stands at $83.5 million. </li>
<li>VCI Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCIG#NASDAQ">VCIG</a>) stock increased by 3.94% to $0.14. The market value of their outstanding shares is at $20.4 million. </li>
<li>Hyperscale Data (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#AMEX">GPUS</a>) shares increased by 3.63% to $0.23. The company's market cap stands at $8.7 million. </li>
<li>AgEagle Aerial Sys (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UAVS#AMEX">UAVS</a>) shares rose 3.39% to $0.14. The market value of their outstanding shares is at $2.0 million. </li>
<li>Castor Maritime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTRM#NASDAQ">CTRM</a>) shares moved upwards by 2.93% to $4.43. The market value of their outstanding shares is at $42.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Nixxy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIXX#NASDAQ">NIXX</a>) shares declined by 9.5% to $2.1 during Wednesday's after-market session. The market value of their outstanding shares is at $8.4 million. </li>
<li>Professional Diversity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPDN#NASDAQ">IPDN</a>) stock decreased by 8.81% to $0.67. The market value of their outstanding shares is at $8.5 million. </li>
<li>XCHG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCH#NASDAQ">XCH</a>) shares declined by 8.68% to $13.26. The company's market cap stands at $786.6 million. </li>
<li>Polar Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POLA#NASDAQ">POLA</a>) stock decreased by 5.0% to $0.49. The market value of their outstanding shares is at $8.6 million. </li>
<li>Surf Air Mobility (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRFM#NYSE">SRFM</a>) stock decreased by 4.77% to $1.6. The market value of their outstanding shares is at $20.5 million. </li>
<li>Singularity Future Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGLY#NASDAQ">SGLY</a>) stock declined by 4.57% to $1.67. The company's market cap stands at $5.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTRM

GPUS

GRFX

IPDN

LGCL

NIXX

POLA

SGLY

SRFM

UAVS

VCIG

12 Industrials Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>AMTD Digital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HKD#NYSE">HKD</a>) shares increased by 33.6% to $5.22 during Wednesday's after-market session. The market value of their outstanding shares is at $1.0 billion. </li>
<li>CCSC Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCTG#NASDAQ">CCTG</a>) stock moved upwards by 11.06% to $1.6. The company's market cap stands at $18.5 million. </li>
<li>Evolv Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVLV#NASDAQ">EVLV</a>) stock rose 7.69% to $4.2. The market value of their outstanding shares is at $661.7 million. </li>
<li>Glimpse Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAR#NASDAQ">VRAR</a>) stock rose 6.15% to $0.77. The company's market cap stands at $13.9 million. As per the press release, Q4 earnings came out 2 days ago. </li>
<li>Iveda Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVDA#NASDAQ">IVDA</a>) shares moved upwards by 4.34% to $1.68. The market value of their outstanding shares is at $3.7 million. </li>
<li>Yxt.Com Group Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YXT#NASDAQ">YXT</a>) stock moved upwards by 4.0% to $2.6. The market value of their outstanding shares is at $156.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Infobird Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFBD#NASDAQ">IFBD</a>) shares decreased by 4.2% to $2.06 during Wednesday's after-market session. The market value of their outstanding shares is at $4.0 million. </li>
<li>Ostin Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) shares fell 3.75% to $0.38. The market value of their outstanding shares is at $5.6 million. </li>
<li>MMTEC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) shares fell 3.54% to $0.74. The company's market cap stands at $147.3 million. </li>
<li>Intchains Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICG#NASDAQ">ICG</a>) shares decreased by 3.02% to $4.5. The company's market cap stands at $270.0 million. </li>
<li>Netgear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTGR#NASDAQ">NTGR</a>) shares decreased by 2.79% to $19.25. The market value of their outstanding shares is at $559.5 million. </li>
<li>BTCS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTCS#NASDAQ">BTCS</a>) stock declined by 2.59% to $1.13. The company's market cap stands at $18.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BTCS

CCTG

EVLV

IFBD

IVDA

NTGR

VRAR

12 Information Technology Stocks Moving In Wednesday's After-Market Session

WIIM

SPRO

Spero Therapeutics shares are trading higher after the company announced the publication of data from its Phase 1 clinical trial, which assessed the intrapulmonary pharmacokinetics of SPR719.

Plans To Increase Valuation And Regain Compliance; Shares Will Continue Trading With ".BC" Designation Indicating Below Compliance Status; No Immediate Impact On Business Operations Or SEC Reporting Requirements

Know Labs Receives NYSE American Noncompliance Notice For Not Meeting Listing Standards

Biotech

Spero Therapeutics Publishes SPR720 Phase 1 Lung Exposure Data In Antimicrobial Agents And Chemotherapy

Ollie&#39;s Bargain Outlet Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/olli#NASDAQ">OLLI</a>) is set to enhance its retail footprint following the acquisition of seven former Big Lots store leases won through a recent bankruptcy auction. This acquisition comes as part of the ongoing restructuring efforts of Big Lots, which included the closure of 143 stores.
<h2>Details of OLLI&#39;s Acquisition of 7 Big Lots&#39; Stores</h2>
Of the seven stores, Ollie&#39;s Bargain has received the final clearance and approval for six stores from the United States Bankruptcy Court for the District of Delaware. The seventh store is expected to receive the necessary approvals soon.
What makes these stores an ideal choice is that these have the required size, situated in prime trade areas and align with OLLI&#39;s commitment to serving value-oriented customers. Not only this but these stores also are located in the Midwest, a region where OLLI sees significant growth potential and has opened a new distribution center.
Similar to the 99 Cent Only stores&#39; acquisition, OLLI&#39;s primary focus is on opening the acquired Big Lots stores while adjusting the schedule for other planned store openings in its pipeline to optimize productivity and reduce pre-opening costs. For fiscal 2024, the company anticipates 50 new stores and two planned closures.
Ollie&#39;s Bargain&#39;s acquisition of former Big Lots stores signifies a strategic growth initiative within the competitive retail landscape. Currently, OLLI operates 541 stores across 31 states. The company&#39;s long-term plan is to operate 1300 stores across the United States.
<h2>What More Should Investors Know About OLLI?</h2>
Ollie&#39;s Bargain business model of &quot;buying cheap and selling cheap&quot;, cost-containment efforts, focus on store productivity and expansion of customer reward program and Ollie&#39;s Army reinforce its position in the industry. Ollie&#39;s Army continues to be a significant sales driver in the second quarter of fiscal 2024 with the increasing membership. The company ended the quarter with 14.5 million active Ollie&#39;s Army members, which accounted for more than 80% of sales. Collectively, these initiatives position the company for sustained growth.
OLLI delivered a strong performance in the second quarter. It emphasizes value-driven merchandise assortments, which allowed the company to seize market opportunities and meet consumer demand effectively. Comparable store sales rose 5.8% in the quarter, driven by growth in transactions and basket size. Ollie&#39;s Bargain has now achieved nine consecutive quarters of comparable store sales growth.
The improved business performance prompted management to lift its fiscal 2024 view. OLLI now expects net sales in the range of $2.276-$2.291 billion compared with $2.257-$2.277 billion stated earlier. Ollie&#39;s Bargain now anticipates comparable store sales to rise in the band of 2.7-3.2% compared with 1.5-2.3% previously stated. The company has revised adjusted EPS to be in the band of $3.22-$3.30, up from the earlier estimated range of $3.18-$3.28.
<h2>How is the Zacks Consensus Estimate Faring for OLLI?</h2>
Reflecting the positive sentiment around OLLI, the Zacks Consensus Estimate for EPS has seen upward revisions. In the past 60 days, analysts have increased their estimates for the current and next fiscal year by 0.3% to $3.28 and 1.1% to $3.72 per share, respectively. These estimates indicate expected year-over-year growth of 12.7% and 13.4%, respectively.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/75/80055.jpg?v=1028948304" />
Image Source: Zacks Investment Research
<h2>Does OLLI Stock Look Attractive?</h2>
In the past six months, OLLI&#39;s shares have gained 38.5%, outpacing the industry and the S&amp;P 500&#39;s growth of 6.8% and 9.9%, respectively.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/da/80057.jpg?v=2118532209" />
Image Source: Zacks Investment Research
OLLI stock has been a strong performer, but its valuation remains a topic of debate. Currently, the stock trades at a premium relative to the industry, with a price-to-earnings ratio indicating that its growth potential may already be factored into price.
OLLI&#39;s forward 12-month price-to-earnings ratio stands at 26.7X, higher than the industry&#39;s ratio of 18.6X. This suggests that investors are paying a premium compared with the company&#39;s expected earnings growth. OLLI has a Value Score of D.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/70/80056.jpg?v=1422364156" />
Image Source: Zacks Investment Research
<h2>How to Play OLLI Stock?</h2>
Ollie&#39;s Bargain is well-positioned to enhance its market presence, drive sales and deliver value to its customers, leading to improved financial performance in the coming quarters. Investors with a long-term horizon may stay invested in this Zacks Rank #3 (Hold) stock but potential investors should look for a better entry point, given its higher valuation.
<h2>Stocks to Consider</h2>
Here, we have highlighted three better-ranked stocks, namely Sprouts Farmers Market, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfm#NASDAQ">SFM</a>), Burlington Stores, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/burl#NYSE">BURL</a>) and Chewy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chwy#NYSE">CHWY</a>), currently carrying a Zacks Rank # 2 (Buy) each.
Sprouts Farmers engages in the retailing of fresh, natural and organic food products under the Sprouts brand in the United States. SFM has a trailing four-quarter earnings surprise of nearly 12%, on average.
The Zacks Consensus Estimate for Sprouts Farmers&#39; current-fiscal year&#39;s sales and earnings indicates growth of 9.6% and 18.7%, respectively, from the year-ago reported numbers.
Burlington Stores operates as a retailer of branded merchandise in the United States. BURL has a trailing four-quarter earnings surprise of 18.4%, on average.
The Zacks Consensus Estimate for Burlington Stores&#39; current-financial year&#39;s sales and earnings implies a rise of 10.1% and 30.5%, respectively, from the year-earlier reported figures.
Chewy engages in the pure-play e-commerce business in the United States. CHWY has a trailing four-quarter earnings surprise of 50.9%, on average.
The Zacks Consensus Estimate for Chewy&#39;s current-financial year&#39;s sales and earnings indicates an increase of 5.7% and 65.2%, respectively, from the year-ago reported numbers.
<a href="https://www.zacks.com/stock/news/2344979/olli-expands-with-7-big-lots-stores-what-more-should-investors-know?cid=CS-BENZ-FT-analyst_blog|company_news_corporate_actions-2344979">To read this article on Zacks.com click here.</a>

Large Cap

Mid Cap

Analyst Ratings

BURL

CHWY

OLLI

OLLI Expands With 7 Big Lots Stores: What More Should Investors Know?

<a href="https://x.com/allyversprille/status/1841574905470386647" title="https://x.com/allyversprille/status/1841574905470386647">https://x.com/allyversprille/status/1841574905470386647</a>

Bloomberg Reporter Post On X, " FAA has concluded its review of United Airlines which followed a spate of safety incidents at the carrier earlier this year. The review didn't identify "any significant safety issues," the regulator said in a statement to Bloomberg.'

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers for Thursday morning as we check out all of the latest news moving shares today!



Moving stocks this morning are earnings reports, disclosed stakes in companies and more.



Let&rsquo;s get into that news down below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>JX Luxventure (NASDAQ:<a href="https://investorplace.com/stock-quotes/jxjt-stock-quote/">JXJT</a>) stock is rocketing more than 345% alongside heavy trading.</li>



<li>China Natural Resources (NASDAQ:<a href="https://investorplace.com/stock-quotes/chnr-stock-quote/">CHNR</a>) shares are soaring over 277% with strong early morning trading.</li>



<li>SoundHound AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/soun-stock-quote/">SOUN</a>) stock is surging more than 67% after Nvidia (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvda-stock-quote/">NVDA</a>) <a href="https://finance.yahoo.com/news/nvidia-reports-stakes-arm-soundhound-222448317.html">reported a stake in the company</a>.</li>



<li>Meihua International Medical Tech (NASDAQ:<a href="https://investorplace.com/stock-quotes/mhua-stock-quote/">MHUA</a>) shares are gaining over 51% with strong pre-market trading today.</li>



<li>Nouveau Monde Graphite (NYSE:<a href="https://investorplace.com/stock-quotes/nmg-stock-quote/">NMG</a>) stock is increasing more than 45% after <a href="https://www.businesswire.com/news/home/20240214552719/en/NMG-Announces-Offtake-Agreement-with-GM-for-Canadian-Graphite-and-US150-Million-Equity-Investment">signing a supply agreement</a> with General Motors (NYSE:<a href="https://investorplace.com/stock-quotes/gm-stock-quote/">GM</a>).</li>



<li>Nano X Imaging (NASDAQ:<a href="https://investorplace.com/stock-quotes/nnox-stock-quote/">NNOX</a>) shares are rising over 38% as Nvidia also revealed a stake in this company.</li>



<li>OLB Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/olb-stock-quote/">OLB</a>) stock is climbing more than 38% on Thursday morning.</li>



<li>Roma Green Finance (NASDAQ:<a href="https://investorplace.com/stock-quotes/roma-stock-quote/">ROMA</a>) shares are jumping over 26% with heavy pre-market trading.</li>



<li>Scorpius (NYSEMKT:<a href="https://investorplace.com/stock-quotes/scpx-stock-quote/">SCPX</a>) stock is getting a 25% boost this morning.</li>



<li>Greenpro Capital (NASDAQ:<a href="https://investorplace.com/stock-quotes/grnq-stock-quote/">GRNQ</a>) shares are up more than 24% as it sees strong trading early this morning.</li>
</ol><h2>Top 10 Losers</h2>



<ol><li>Treasure Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/tgl-stock-quote/">TGL</a>) stock is plummeting close to 44% after releasing a <a href="https://www.nasdaq.com/press-release/treasure-global-reports-second-quarter-fiscal-year-2024-results-2024-02-14">mixed fiscal Q2 2024 earnings report</a>.</li>



<li>Cineverse (NASDAQ:<a href="https://investorplace.com/stock-quotes/cnvs-stock-quote/">CNVS</a>) shares are retreating over 37% following the <a href="https://www.nasdaq.com/press-release/cineverse-reports-third-quarter-fiscal-year-2024-results-2024-02-14">release of its Q3 earnings report</a>.</li>



<li>Renalytix (NASDAQ:<a href="https://investorplace.com/stock-quotes/rnlx-stock-quote/">RNLX</a>) stock is tumbling more than 31% after <a href="https://www.nasdaq.com/press-release/renalytix-reports-financial-results-for-second-quarter-of-fiscal-year-2024-2024-02-15">releasing results for its latest quarter</a>.</li>



<li>Fresh2 Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/fres-stock-quote/">FRES</a>) shares are taking an over 30% beating on Thursday morning.</li>



<li>Clean Energy Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/cety-stock-quote/">CETY</a>) stock is sliding more than 28% without any obvious news today.</li>



<li>Earlyworks (NASDAQ:<a href="https://investorplace.com/stock-quotes/elws-stock-quote/">ELWS</a>) stock is pulling back over 29% <a href="https://investorplace.com/2024/02/why-is-earlyworks-elws-stock-up-340-today/">after a massive rally yesterday</a>.</li>



<li>Upexi (NASDAQ:<a href="https://investorplace.com/stock-quotes/upxi-stock-quote/">UPXI</a>) shares are falling more than 26% <a href="https://finance.yahoo.com/news/upexi-reports-fiscal-second-quarter-210500871.html">following a rough Q2 earnings report</a>.</li>



<li>Addentax (NASDAQ:<a href="https://investorplace.com/stock-quotes/atxg-stock-quote/">ATXG</a>) stock is dropping over 26% with its <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318065266&amp;type=PDF&amp;symbol=ATXG&amp;cdn=1f758177ea2228606438e3a5fa8aaf7f&amp;companyName=Addentax+Group+Corp.&amp;formType=10-Q&amp;formDescription=General+form+for+quarterly+reports+under+Section+13+or+15%28d%29&amp;dateFiled=2024-02-14">latest earnings release</a>.</li>



<li>Healthcare Triangle (NASDAQ:<a href="https://investorplace.com/stock-quotes/hcti-stock-quote/">HCTI</a>) shares are slipping more than 25% <a href="https://seekingalpha.com/news/4067041-healthcare-triangle-stock-jumps-on-new-saas-solution-to-drive-ai-integration-in-healthcare?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain">following a rally late yesterday</a>.</li>



<li>United States Antimony&nbsp;(NYSEMKT:<a href="https://investorplace.com/stock-quotes/uamy-stock-quote/">UAMY</a>) stock closes out our pre-market stock movers down over 24%.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/02/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-feb-15th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

NNOX, BBAI and RGTI are among pre market gainers

Meihua International Medical Technologies Co., Ltd. (MHUA) has released an update. Meihua International Medical Technologies Co., Ltd. has been not...

Meihua Faces Nasdaq Delisting Over Price Rule

Meihua International Medical Technologies Co., Ltd. (MHUA) has released an update. Meihua International Medical Technologies Co., Ltd. (MHUA) repor...

Meihua International Reports Profit Surge in 2023

Meihua GAAP EPS of $0.49, revenue of $97.1M

Meihua International Medical Technologies Co., Ltd. (MHUA) has released an update. Meihua International Medical Technologies Co., Ltd., a distingui...

Meihua International to Woo Investors at Upcoming Conferences

Meihua International Medical Technologies Co., Ltd. (MHUA) has released an update. Meihua International Medical Technologies Co., Ltd. (MHUA) has e...

Meihua International Announces Share Buyback Plan

Meihua International authorizes $3M share buyback program

Meihua International Medical Technologies Co., Ltd. (MHUA) has released an update. Meihua International Medical Technologies Co., Ltd. has reported...

Meihua International Strengthens Financial Position

Meihua reports 1H results

ATXG

BBAI

CETY

CHNR

CNVS

ELWS

FRES

GFAI

GRNQ

HCTI

JXJT

MHUA

NNOX

PLCE

RGTI

RNLX

ROMA

SCPX

SOUN

UAMY

UPXI

Press Releases

Meihua International Medical Technologies Co., Ltd. to Present at the Emerging Growth Conference on May 9, 2024

Presenting on the Emerging Growth Conference 70 Day 2 on May 9 Register Now

Meihua International Medical Technologies Co., Ltd. to Present at the Sidoti Small Cap Conference and Update Investors at the Emerging Growth Conference on June 13, 2024

Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now

Events

Sidoti Events, LLC's Virtual June Small-Cap Conference

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million

Meihua International Medical Technologies Facilitates World's Second* 5G Remote Robot-Assisted Lobectomy

Meihua International Medical Technologies Co., Ltd. to Present at LIVE! with Webull Corporate Connect: Virtual Healthcare Investment Webinar on August 28, 2024

Meihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial Results

Comments

Meihua Intl Medical Techs

Interés en corto

Meihua Intl Medical Techs (NASDAQ:MHUA) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL